Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00454532
Status:
COMPLETED
Last Update Posted:
2012-03-16
First Post:
2007-03-26
Brief Title:
A Phase III Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
Sponsor:
Bionovo
Organization:
Bionovo
Organization Data
Organization:
Bionovo
Class:
INDUSTRY
Study ID:
BZL-101-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bionovo
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None